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Summary
Spinal epidural abscess (SEA) is a rare but severe
infection requiring prompt recognition. The major
prognostic factor for a favourable outcome is early
diagnosis, leading to appropriate treatment. In
clinical practice, a diagnosis of SEA is often not
considered, particularly in the early stages of the
disease when neurological symptoms are not
apparent. Knowledge of persons at risk, clinical
features and the required diagnostic procedures may
decrease the number of initially misdiagnosed cases.
Clinical signs, duration of symptoms and the rate
of neurological deterioration show a high inter-
individual variability, and the classic triad (spinal
pain, fever and neurological deficit) is often not
found, especially not at first presentation to a
physician. However, most patients complain of
severe localized back pain. Inflammatory para-
meters in the blood are generally elevated, but not
specific. Gadolinium-enhanced magnetic resonance
imaging is the most sensitive, specific and accurate
imaging method. Although neurosurgical decom-
pression is still the treatment of choice in the
majority of cases, less invasive procedures (e.g.
computed tomography-guided needle aspiration) or
antimicrobial treatment alone can be applied in
selected cases. The choice of the most appropriate
therapy should be discussed immediately after a
confirmed diagnosis in consultation with infectious
disease, radiology and spinal surgery specialists. The
outcome of SEA is largely influenced by the severity
and duration of neurological deficits prior to surgery,
stressing the importance of early recognition.
Introduction
Spinal epidural abscess (SEA) represents a diagnostic
challenge in clinical practice. Prior to the appear-
ance of neurological deficits, its signs and symptoms
are applicable to a broad range of possible
diagnoses. The combination of low incidence and
non-specific symptoms such as back pain or
localized spinal tenderness can make early recogni-
tion difficult. Unrecognized SEA may not only
progress to potentially irreversible pareses, but also
to life-threatening sepsis. A high degree of aware-
ness can lead to rapid detection of SEA and thus a
better prognosis. Clinicians assessing a patient at an
early stage need to initiate the correct diagnostic
work-up promptly, and so internists, primary care
physicians and emergency medicine physicians are
the target readers of this review.
Epidemiology
In 1975, Baker et al.1 reported an incidence of SEA
ranging from 0.2 to 1.2 per 10 000 hospital
admissions per year. Since then, several studies
have shown that the incidence is rising. The current
annual incidence is estimated to be 2.5–3 per
10 000 hospital admissions.2–10 This trend can be
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partly explained by the growing number of patients
with predisposing conditions or risk factors, such as
diabetes mellitus, higher age or intravenous drug
use. Instrumentation of the vertebral canal by
anaesthetic interventions is also a risk factor con-
tributing to the incidence rate of SEA. Part of the
increase may also be artefactual, and due to the
improved sensitivity of the now broadly available
neuroradiological imaging techniques. It is conceiv-
able that previously, in some patients, epidural
abscesses were not recognized, and were diagnosed
and treated as spondylitis.
SEA occurs in all age groups.11 However, a
greater prevalence between the fifth and seventh
decade of life3–8,12 and a male predominance4,6–8,11
have been described in many studies. This might be
due to the fact that the reported predisposing
conditions and risk factors are more prevalent in
older people.
Key points for clinical practice
The annual incidence of SEA is estimated to be 2–3
per 10 000 hospital admissions. Prevalence is great-
est between the fifth and seventh decades of life.
Anatomy
Spinal epidural infection is characterized by a
collection of pus or inflammatory granulation
tissue between the dura mater and the overlying
vertebral column. The spinal epidural space
(Figure 1) is a continuous vertical sleeve largely
filled with fat, arteries and venous complexes. In the
lumbar region, however, the dura approaches the
periosteum, giving the appearance of a segmented
sleeve. There is a true epidural space posterior and
lateral to the spinal cord. In contrast, the anterior
area is almost virtual, since the dura, the posterior
longitudinal ligament and the periosteum of the
vertebral body are in close contact with each other.
The posterior area is small in the cervical region,
but larger in the midthoracic (T4–T8) and lumbosa-
cral (L3–S2) part of the spine. It is plausible that the
location and extent of SEA are associated with
anatomical structures. As the abscess increases in
size, it extends along the dural sheath, and therefore
usually involves several segments.3–7,13,14 SEA is
typically located in the ‘true’ posterior space.
Abscesses located anterior of the spinal cord are
frequently but not exclusively associated with
vertebral osteomyelitis.3,5,6 In most studies, SEA is
predominantly located in the thoracic and lumbo-
sacral region.3,4,6,7,11,14,15 This parallels the most
frequent localization of vertebral osteomyelitis, and
the preferred puncture site of instrumentation of the
vertebral canal.16,17
Key points for clinical practice
SEA usually involves several segments. SEA is
predominantly located in the posterior thoracic
and lumbosacral spine. Abscesses located in the
anterior epidural space are frequently associated
with vertebral osteomyelitis.
Pathogenesis
Bacteria gain access to the epidural space by three
mechanisms: (i) per continuitatem from a neigh-
bouring infected structure; (ii) through haematogen-
ous dissemination from a remote focal infection; or
(iii) through iatrogenic inoculation. However, in
30–40% of the cases, no source can be identified,
indicating silent bacteraemia seeding in the epidural
space.3,4,18
Direct extension usually originates from vertebral
osteomyelitis or psoas muscle abscess. This
mechanism is estimated to be responsible for
10–30% of cases.3,11,18 Thus, it is important to
evaluate and monitor the extent of the primary
infection.
In 50% of cases, microorganism reach the
epidural space through haematogenous seeding.
Skin, soft-tissue, urinary and respiratory tract infec-
tions are frequent primary sources (Table 1).
Importantly, as a result of haematogenous dissemi-
nation, SEA may occur discontinuously at several
levels of the spine. This should be taken into
consideration when spinal tenderness is assessed
and imaging studies planned.
Iatrogenic causes of SEA include all kinds of
invasive procedures, such as surgery, lumbar
puncture, peridural anaesthesia, epidural analgesia
Figure 1. Cross-section through a vertebra. Epidural
space.
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and nerve blocks, and are estimated to be respon-
sible for 15% of all cases.1,3–7,11,18–23 In general,
these infections are acquired either during the
invasive procedure itself, or through ascending
microorganism from the skin flora, when a device
is left in place.24–26 On such catheters, there is a
biofilm formation similar to that found on intravas-
cular catheters. Another possible iatrogenic cause of
SEA that clinicians should be aware of, is the
paraspinal injection of analgesics and steroids (e.g.
for local pain therapy).13,27–29
Spinal cord injury leading to neurological
impairment is partially caused by direct mechan-
ical compression by the inflammatory mass.
Accordingly, there is notable neurological improve-
ment after surgical decompression.30 Studies
focussing on the indirect injury caused by
vascular occlusion and ischaemia have shown
diverging results.31,32 Mechanical compression
and vascular occlusion may occur at different
phases of the disease and cause additive
adverse effects. However, the detailed patho-
genesis of spinal cord injury remains poorly
characterized.
Key points for clinical practice
SEA can occur simultaneously on several segments
of the spine. In case of severe spinal tenderness
occurring during or after any focal infection or
sepsis, SEA must be considered as a diagnosis. In
the case of vertebral osteomyelitis or psoas
muscle abscess, SEA must be actively looked for.
Previous invasive spinal procedures, including
paravertebral injections of analgesics and steroids
for local pain therapy, represent a possible source of
infection.
Predisposing conditions and risk
factors
A large proportion of SEA patients have at least one
predisposing factor (Table 2). Most of these, includ-
ing diabetes mellitus, intravenous drug use, immu-
nosuppressive therapy, cancer, HIV/AIDS and renal
failure are predisposing conditions for any type of
severe infection. Spinal abnormalities, such as
degenerative joint disease or scoliosis, have been
advocated to represent a locus minoris resistentiae.
A history of previous spinal trauma is often evident
in SEA. Haematoma and disruption of anatomic
barriers favour the development of SEA.11
Alcoholism is found in a relatively high propor-
tion of patients with SEA. Alcohol intoxication
predisposes to injury, including spinal trauma, and
decreases pain sensitivity, resulting in pressure sores
or muscle damage. Moreover, there is a high risk for
missing the diagnosis of SEA in this population,
because symptoms might be misinterpreted as
typical sequelae of alcoholism, such as pancreatitis,
peripheral neuritis, and vitamin B12 deficiency.20
The risk of SEA in association with invasive
procedures has been estimated for some invasive
anaesthetic interventions and ranges from 1:1000 to
1:100 000, depending on the study population, and
the location and duration of catheterization.26,33–40
In the case of temporary puncture, the risk of an
epidural abscess is very low. Two recently published
studies,23,41 each analysing the outcome of48000
epidural catheters inserted for postoperative analge-
sia, calculated an SEA incidence of approximately
1:1350. However, if a peri- or epidural catheter
is left in place for several days (e.g. for more than
2–4 days), the risk of developing both catheter
site infection and epidural abscess increases
Table 1 Primary sources of infection in spinal epidural
abscess
Source of infection Median (%) Range (%)
Skin and soft tissue 18 7–45
Urinary tract 10 2–36
Previous sepsis of
unknown origin
8 5–11
Respiratory tract 5 3–16
Abdomen 4 2–11
Endocarditis 3 1–8
Infected vascular access 2 1–8
Dental abscess 2 1–11
Ear, nose and throat 2 <1–11
Based on references 1, 3–7, 11, 18–22.
Table 2 Predisposing conditions in spinal epidural
abscess
Predisposing condition Median (%) Range (%)
Diabetes mellitus 21 15–46
Abnormality of the
vertebral column
17 6–70
Trauma of the spine 15 5–33
Intravenous drug use 15 4–37
Immunosuppressive therapy 12 7–16
Cancer 7 2–15
HIV/AIDS 6 2–9
Alcoholism 5 4–18
Chronic renal failure 4 2–13
Based on references 1, 3–7, 11, 18–22.
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significantly.23,41,42 The true incidence of SEA after
paravertebral injection for pain therapy, in particular
when performed repeatedly, is difficult to establish,
because the frequency of this debated practice and
its complications may be underreported. Thus, it
might be possible that these interventions out-
number other iatrogenic causes of SEA.29,43
However, preceding anaesthetic practices must be
actively sought when evaluating the patient’s
history.
Key points for clinical practice
Awareness of co-morbidities can speed up the
identification of patients prone to infections. Spinal
abnormalities and a history of spine trauma are
predisposing conditions for SEA. The risk of acquir-
ing SEA during anaesthetic practices is low, but
increases with time when peri- or epidural catheters
are left in place. Preceding anaesthetic practices
must be actively sought when evaluating a patient’s
history.
Clinical features
Many clinical features are non-specific, even in an
emerging case of SEA, particularly if the circum-
stances are not considered. However, if a thorough
evaluation of the patient’s history reveals predispos-
ing or risk factors for SEA, the constellation of
several symptoms and signs should raise the
suspicion of this diagnosis.
Classical symptoms of SEA include spinal pain,
fever and neurological deficits. However, according
to two recent studies, this triad is only present in
10–15% of the cases at first physician contact.44,45
Common reported symptoms and signs at the time of
diagnosis are listed in Table 3. Back pain and
severe, circumscribed tenderness are by far the most
frequent early findings. Thus, patients are at risk of
receiving inappropriate treatment such as analgesics
for back pain due to degenerative spinal disease.
However, many patients describe the pain as ‘the
worst they ever had’,18 and are able to distinguish
the pain character from chronic back pain. When
asked about the ache type, some patients report
sharp or lancinating pain, like ‘being stabbed in the
back’.8,18 Nevertheless, since the differential diag-
nosis of back pain is large, and the pain type does
not reliably indicate SEA, diagnosis of SEA is still
likely to be missed, particularly at early stages.1,4
Therefore, considering a diagnosis of SEA in the
differential diagnosis is crucial for early detection
and outcome. This also holds true for patients with
dominating signs of sepsis, in whom neurological
symptoms may not be noticed, although the
combination of fever, meningism and/or neurologi-
cal deficits might occur more frequently at late
stages of the disease. Importantly, a thorough
neurological examination, including the evaluation
of reflexes, sensory and motor functions, anal
sphincter tonus and the ability to completely void
the bladder is mandatory in patients presenting with
severe localized back pain. Special attention should
be paid to the extremities and dermatomes corre-
sponding to the affected spine level. Grading the
muscle activity (i.e. British Medical Council
M-scale, M5 to M0) can also be helpful to follow
the motor function during the course of the disease.
In 1948, Heusner summarized the clinical
features and progression of SEA in four stages
(Table 4).46,47 This staging system is still a valuable
tool, because it potentially points to the diagnosis of
SEA before the appearance of irreversible neurolo-
gical damage. However, additional information is
needed for clinical practice. In stage II, signs of
nerve root compression may present as typical
radicular pain, but have also been described as
Table 3 Symptoms and signs at diagnosis of spinal
epidural abscess
Signs/symptom Median (%) Range (%)
Back pain 75 72–100
Tenderness 58 17–98
Motor weakness 40 26–87
Radicular pain 38 19–57
Sensory abnormalities 36 13–45
Fever 32 13–95
Bladder and bowel dysfunction 27 9–37
Paralysis 27 5–39
Neck stiffness 16 2–24
Confusion 14 7–28
Headache 14 3–24
Nausea/vomiting 8 1–8
Based on references 1, 4–6, 8, 11, 14, 18, 19, 55, 70, 71.
Table 4 Stages according to clinical progression of
spinal epidural abscesses
Stage Clinical signs
I Back pain, fever, tenderness
II Radicular pain, nuchal rigidity/neck stiffness,
reflex changes
III Sensory abnormalities, motor weakness, bowel
and bladder dysfunction
IV Paralysis
Based on references 46, 47.
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‘electric shocks’ or ‘shooting’.1 Depending on the
spine level involved, the pain can radiate to the
abdomen, chest wall or neck, and mimic other
diseases such as pancreatitis or heart disease.20,48
Sensation alterations such as numbness may already
indicate stage III and should alert the physician to
the severity of the disease. Subtle signs of motor
weaknesses, bowel and bladder dysfunction may
not be realized or reported by the patient, and must
be actively looked for, as discussed above. Once
complete loss of muscle activity (paralysis) devel-
ops, stage IV according to Heusner, it quickly
becomes irreversible, stressing the seriousness of a
delayed diagnosis.
The duration of symptoms and the rate of
neurological deterioration are highly variable.3,4,30
The time between symptom onset and the patient
consulting a physician or appearing in the
emergency department can range from a few
days to more than a month.19 Furthermore, neuro-
logical deterioration can progress to complete loss
of muscle activity within a few hours, or alterna-
tively to only slight impairments within several
days.1,4,6,49 This unpredictable course underlines
the difficulty in diagnosing SEA, and the importance
of repeating a thorough neurological examination
frequently.
In contrast to other infectious diseases such as
osteomyelitis, a subclassification into acute and
chronic SEA is not clinically useful, because it
shows poor correlation to specific aetiological
agents, and does not significantly influence the
choice of treatment or the outcome.4,6,50,51
Key points for clinical practice
SEA shows a large variability in clinical signs,
duration of symptoms and the velocity of progres-
sion of neurological deficits. At an early stage of
disease, the so-called classical triad (spinal pain,
fever and neurological deficits) is not common.
Severe localized back pain is the most frequent
reported symptom and should induce more specific
diagnostic tests. In suspected or identified SEA cases,
frequent neurological examination is required.
Illustrative case report 1
A 62-year-old man was evaluated for the new onset
of severe backache and fever. His medical history
included psoriasis. Physical examination revealed
no evidence of neurological deficits. Analyses of
inflammatory parameters in the blood showed
8.2109/l white blood cells (WBC, normal
4–10109 cells/l) and 24mg/l C-reactive protein
(CRP, normal <5mg/l). The values were interpreted
as a response to a viral infection. Analgesic treatment
included intramuscular application of diclofenac.
However, the symptoms persisted. Two days later,
WBC had increased to 12.0 109 cells/l and CRP
to 300mg/l. Staphylococcus aureus sepsis was
documented and intravenous flucloxacillin started.
Because of the severe cervical pain, magnetic
resonance imaging (MRI) of the cervical spine
was performed, and revealed spondylodiscitis
complicated by an SEA at the C6-7 level (Figure 2,
A and B).
Figure 2. MRI. T2-weighted image (A) and T1-weighted fat-saturated image after intravenous gadolinium (B), showing
spondylodiscitis (arrow) complicated by an SEA at the C6–7 level (arrowheads).
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Comment
Patients suffering from a chronic dermatological
disease such as psoriasis have an increased risk for
Staphylococcus aureus carriage, similar to patients
with insulin-dependent diabetes.52,53 This patient
complained of severe back pain and fever without
any localizing neurological symptoms. Fever and
new-onset severe back pain combined with a
risk factor for Staphylococcus aureus sepsis54
motivated the specific diagnostic test (MRI) which
revealed SEA prior to the appearance of neurologi-
cal deficits.
Diagnosis
Laboratory studies
Inflammatory markers such as WBC count, CRP and
erythrocyte sedimentation rate (ESR), are generally
elevated. Leukocytosis is found in 60–80%, and an
ESR420mm/h in up to 95% of cases.4–7,14,18–21,55
These laboratory parameters might be supportive,
but they are not specific for SEA. In Europe,
measuring CRP has replaced ESR as a test to
indicate (acute) inflammation. In the study of
Soehle and Wallenfang,5 the mean CRP of
25 patients with SEA was 1509mg/l (normal
<5mg/l).
Imaging studies
MRI with gadolinium (Gd-MRI) has a specificity and
sensitivity above 90% to detect SEA, and being
superior to other imaging modalities, is therefore the
diagnostic method of choice.56–58 MRI is also the
most sensitive and specific test for the diagnosis of
infection in patients with low back pain, enabling
detection of vertebral osteomyelitis.59 It identifies
signal abnormalities indicating spinal cord
ischaemia and acute transverse myelopathy. In
T1-weighted images, SEA and the spinal cord have
the same intensity. SEA suppresses the signal from
the cerebrospinal fluid (CSF) by gadolinium
enhancement, and can thereby be anatomically
localized.60 The use of fat-saturated images
allows the detection of additional bone marrow
oedema and soft-tissue inflammation, and therefore
the extent of the infection. In T2-weighted images,
SEA often shows a signal increase, but there
are variations in this pattern (Figure 2A), leading
to possible difficulties when interpreting image
findings.61,62 Thus, it is helpful to compare
T2- with T1-weighted images on which the infected
area is enhanced by the contrast medium
(Figure 2B).
MRI findings may also correlate with outcome.
In a study including 18 patients, central stenosis
of 550% and an abscess length of 43 cm
were significantly associated with a worse
outcome.63
CT with intravenous contrast media has been
proposed as an alternative diagnostic tool, although
its sensitivity, specificity and accuracy are lower
than those of MRI.56–59 Myelography followed by
CT is as sensitive as MRI, but has the following
limitations. Compared to MRI, it is an ‘invasive’
intervention and exposes the patient to ionizing
radiation.6,8,55 Also, it typically shows a block to
contrast medium flow at the level of the SEA, but
cannot identify the cause of the thecal sac compres-
sion. Other lesions revealing similar radiological
findings to those of SEA include epidural lipomatosis
or cancer metastasis.64,65 Furthermore, a complete
block to contrast-liquid flow reveals only the
upper or lower level, but not the full extent of the
abscess. Finally, this procedure carries the risk of
additionally contaminating the subarachnoidal
space, with subsequent meningitis. Based on these
arguments, myelography is generally no longer
recommended. However, in very selected cases
(e.g. patients who cannot undergo MRI examina-
tions, further elucidation of inconclusive MRI or CT
findings), myelography may represent an additional
alternative.66
Other imaging methods (plain radiograph or
nuclear scintigraphy) are not diagnostic for SEA,
but may reveal indirect signs of concomitant spinal
infections.
Repeating imaging studies, after initial
negative findings
In a case of unremarkable or inconclusive MRI
findings, but high clinical and laboratory suspicion
for SEA, repeated imaging studies are required.
However, the optimal method of, and interval until,
the second investigation are both unknown. The few
published data appear to favour CT-myelogra-
phy,6,8,18,67 which is meaningful if a definite
diagnosis is required within a short period of time
after the initial imaging study. However, in the
absence of neurological deficits and urgency for
surgical intervention, repetition of Gd-MRI might be
preferable. The interval between the first and second
image study has varied greatly in the cases we have
investigated (range 0–16 days), and was mainly
based on the clinical course.67,68 What is important,
however, is that imaging is repeated rapidly in a
case of neurological deterioration or insufficient
clinical and laboratory response to antimicrobial
treatment.
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Microbiological studies
It is important to cultivate the causative microorgan-
ism, from blood and/or from the abscess. Since
a large proportion of SEAs are caused by haemato-
genous dissemination, additional sampling from
potential sources of infection may be beneficial.
This is supported by the fact that in 10–15% of cases
Gram-negative rods are isolated, and these are
mostly associated with urinary tract infections.
CT-guided needle aspiration of the abscess should
be performed early, because blood cultures remain
negative in 40% of cases.44,45 Specimens can also
be obtained from surgical drainage for decompres-
sion. Previous antimicrobial therapy decreases the
sensitivity of culture results. However, although
adequate medical treatment requires identification
of the causative pathogen, antibiotics should not be
withheld simply to improve the sensitivity of the
abscess culture, and the decision whether or not to
administer antibiotics prior to an invasive interven-
tion must be based on the patient’s clinical
condition (see Treatment below).
A large variety of pathogens have been found as
causative agents for SEA, including mycobacteria,
fungi and parasites,11 but S. aureus is by far the most
frequent. Table 5 summarizes the microbiology from
508 patients published in the literature.
Cerebrospinal fluid
Lumbar puncture plays a less important role in
diagnosing SEA, and should not be performed
routinely. Neither Gram staining (generally nega-
tive), nor cultures of CSF (growth in 6–28%) reveal
results with acceptable sensitivity.3,4,18,68 The cell
count is generally elevated, but varies widely (20 up
to several thousand cells/mm3).1,4,6,7,18–20,68,69
Chemical analysis almost uniformly shows a protein
level of40.45 g/l and a lactate value42mol/l.18,68
But although these findings are typical, they are not
specific for SEA. However, in selected cases with a
high clinical suspicion of SEA and unremarkable
MRI, signs of parameningeal inflammation in the
CSF may indicate a false-negative imaging study. In
addition, the sensitivity and specificity of micro-
biological and chemical CSF analyses may be
higher in the presence of encephalitis (4–35% of
SEA cases).1,4–6,8,11,14,18,19,55,70,71 Nevertheless, the
potential risk of adverse events after lumbar
puncture is undeniable, and awareness of them is
clinically important. As the needle passes through
the abscess, pathogens might migrate to the
meninges or subdural space, resulting in expansion
of the infection. Thus, the location and extent of the
SEA (or suspected SEA) should be carefully evalu-
ated on imaging studies for correct needle place-
ment. Where there is an obstructive hydrocephalus
or complete subarachnoid block, removal of CSF
contains the risk of downward spinal coning.72
Therefore, CT or MRI of the brain is mandatory prior
to performing lumbar puncture. Taking all these
considerations together, CSF should only be har-
vested in selected cases, or when myelography is
indicated.
Key points for clinical practice
CRP is almost always elevated, but is not specific.
Once SEA is considered, MRI is the imaging method
of choice. In addition to blood cultures, which
remain negative in 40% of the cases, CT-guided
needle aspiration of the abscess should be
attempted. Sampling from possible sources of
infection should be included in microbiological
studies. CSF should only be sampled in selected
cases. In the CSF, pleocytosis and a high level of
protein and lactate are typical, but not specific.
Illustrative case report 2
A 54-year-old insulin-dependent diabetic man was
evaluated for back pain of 1 week duration. He was
treated with oral analgesics without pain relief for
2 days. A CT scan of the thoracic spine revealed
neither musculoskeletal pathologies, nor a focus of
infection. Meanwhile, the patient suffered from
fever, recurrent chills and paresis of the right arm.
Analyses of inflammatory parameters in the blood
showed WBC of 18.2109/l (normal 4–10 109
cells/l) and a CRP of 288mg/l (normal <5mg/l).
S. aureus grew in blood cultures, and parenteral
Table 5 Infective agents in 508 patients with spinal
epidural abscesses
Pathogen %
Staphylococcus aureus 60
Gram-negative rods 10
Escherichia coli 3
Pseudomonas aeruginosa 2.5
Klebsiella spp. 1
Streptococcus spp. 9
Viridans group streptococci 2
Streptococcus agalactiae 1.5
Streptococcus pneumoniae 1.5
Enterococcus spp. 1
Coagulase-negative staphylococci 4.5
Anaerobes 2
Mycobacterium spp. <1
Based on references 1, 3–8, 14, 18, 19, 22, 45, 55, 79, 88.
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antibiotics were administered. Two days after the CT
scan, Gd-MRI revealed a SEA delineating from the
vertebral level C5 to T5 (Figure 3).
Comment
In this febrile, diabetic patient with back pain, the
diagnosis of SEA was initially not suspected. During
the course of the disease, he presented with the
classical triad, including back pain, fever and
neurological deficits. The CT scan was done to
search for musculoskeletal pathologies. It showed
neither direct nor indirect signs of SEA. In view of
the large extent of the abscess, it is likely that
Gd-MRI would have revealed the diagnosis at first
presentation. This case illustrates that Gd-MRI has a
higher sensitivity than a normal CT scan and should
therefore be the method of choice in SEA.
Treatment
The management of SEA should always be multi-
disciplinary and involve spinal surgeons, radiolo-
gists and infectious disease specialists. Drainage
of the abscess and eradication of the microorgan-
ism are the basic principles of therapy. Treat-
ment recommendations in SEA are largely based
on retrospective studies, case series and expert
opinions.
Empirical antimicrobial treatment
Antibiotics should be administered after cultures
from blood and other possible sources of infection
have been obtained. To increase the sensitivity of
microbiological results, medical treatment can be
slightly delayed and given immediately after the
invasive procedure. In these cases, the absence of
severe signs of infection and neurological deficits as
well as prompt intervention are mandatory.
Intravenous therapy must include anti-staphylococ-
cal activity, as well as antimicrobial activity against
streptococci and Gram-negative bacilli (e.g. amox-
icillin/clavulanic acid, 2.2 g intravenously three
times daily; or cefuroxime 1.5 g intravenously four
times daily). Regional epidemiological data about
methicillin-resistant S. aureus (MRSA) are decisive
for the empiric use of glycopeptides. Previous
history and clinical findings should influence the
choice of agents. Pseudomonas spp. are associated
with intravenous drug use. Coagulase-negative
staphylococci are typically cultured in the presence
of implanted devices, including epidural catheters.
Once the causative pathogen is identified, antibiotic
treatment should be streamlined accordingly.
Depending on the size of the abscess and the
severity and duration of neurological deficits, the
following three treatment options should be dis-
cussed interdisciplinarily.
Surgical decompression, drainage and
antimicrobial therapy
Surgical therapy is the treatment of choice in the
overwhelming majority of cases. Rapid surgical
intervention is not only needed to minimize neuro-
logical damage, but also for controlling sepsis.
The evaluation of the indication for decompressive
surgical intervention should always urgently be
Figure 3. MRI. T1-weighted fat-saturated images after
intravenous gadolinium, revealing a posterior SEA, from
the vertebral level C5 to T5 (arrowheads).
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considered, since neurological improvement is
unlikely if the duration of paresis exceeds 24–36 h.
Based on the location and extent of the SEA, as well
as intra-operative findings (e.g. use of intra-operative
ultrasonography), the surgical approaches
include laminectomy, hemilaminectomy or inter-
laminar fenestration.3,8,9,12,18,29,70
CT-guided needle aspiration combined
with antimicrobial therapy
This diagnostic procedure might also be therapeutic
by reducing the size of the inflammatory mass.
To date, this method has only been reported in a few
cases, and indication for this treatment is not clearly
defined. Selected patients with a posterior SEA,
no neurological deficit or high surgical risk, and
who do not respond satisfactorily to antimicrobial
treatment alone might benefit from this alternative
method.71,73–75
Conservative therapy with antibiotics
alone
This option might be used in patients who are
unable to undergo an invasive intervention due to
high surgical risk. In the case of complete paresis
for 43 days, a surgical intervention is unlikely to
improve the neurological deficits. Thus, in these
cases, surgery is indicated if antibiotics alone are not
sufficient to control the infection. On the other
hand, conservative therapy might also be used in
patients not suffering from severe loss of spinal cord
or cauda equina function. In these cases, frequent
evaluation of the neurological status and follow-up
laboratory and imaging studies are required. To
monitor abscess size, Gd-MRI should be repeated
after 2–4 weeks.78 Referral to a surgical spine centre
without delay must be guaranteed if the abscess
persists or, even more importantly, if neurological
deterioration occurs. In general, non-surgical treat-
ment failure is apparent during the first 48–72 h after
the onset of therapy.6 However, it may also occur
at later stages.44,45,55,76–78
Duration of antimicrobial treatment
There are no uniform recommendations about
treatment duration in SEA, either for the intravenous
or the subsequent oral regimen. Furthermore, studies
on the bioavailability of antimicrobial agents in the
epidural space are lacking. In the literature, the total
duration of therapy varies between 4 and 16 weeks,
depending on co-morbidities, type of treatment
(medical vs. surgical), isolated microorganism,
bactericidal effect of the available agent and
concomitant spinal infection.8,9,55 Generally,
resolution of the abscess is achieved after 4–6
weeks of treatment.4 In the case of concomitant
vertebral osteomyelitis, treatment is prolonged to
8–12 weeks.3,5,9,12,48,79 The minimal length of
intravenous treatment is not defined, but if con-
comitant spinal infection is absent, in most studies a
treatment duration of at least 3–4 weeks is
suggested.3,12,48,70 Shorter intravenous treatment
has only been described in a few cases, and was
not associated with treatment failure.5,77 In the case
of concomitant vertebral osteomyelitis, parenteral
antibiotics are given for 6–8 weeks.3,12 It is
important to note that intravenous therapy of
vertebral osteomyelitis for <4 weeks might lead to
treatment failure.80,81 This may not be true if
antimicrobial agents with excellent oral bioavail-
ability can be used. This is the case for quinolones in
the case of susceptible Gram-negative organisms, or
the combination of quinolones plus rifampin for
susceptible staphylococci.81–83 However, the role of
these regimens has not been evaluated in patients
with SEA.
Treatment success needs to be confirmed by
follow-up imaging studies 4–8 weeks after ther-
apy.84 The focus should be on soft tissue and
not bony findings.85 Repeating imaging studies at a
later stage (e.g. 6 months) is not required if clinical
and laboratory investigations are unremarkable.86
Key points for clinical practice
The management of SEA should always be
multidisciplinary and evaluated urgently. Empiric
antimicrobial treatment should include anti-
staphylococcal agents and cover streptococci and
Gram-negative bacteria. The empiric regimen must
be adapted according to regional epidemiological
data (MRSA) and predisposing conditions. Based on
the size of the abscess and the severity and duration
of neurological deficits, the best suitable treatment
option (surgical decompression and drainage,
CT-guided needle aspiration or antibiotics alone)
should be chosen, monitored and repetitively
evaluated. Duration of antimicrobial treatment is
usually 4–6 weeks for SEA, and 8–12 weeks in the
case of concomitant vertebral osteomyelitis.
Outcome
In SEA, two factors are crucial for the assessment
of the outcome: mortality and recovery from
neurological deficits. Mortality rates range from
2% to 20%; death is usually due to severe sepsis
and typically occurs in patients with multiple
co-morbidities.4,5,8,18,55 As with other severe infec-
tions, leukocytosis at admission (414 109/l) or
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thrombocytopaenia (<100 109/l) are associated
with a worse outcome.5,14 CRP levels at the time
of diagnosis do not predict the outcome. However,
CRP levels in the second week after admission can
be a prognostic marker.5
Other factors associated with poorer outcome
include the presence of MRSA, prior spinal surgery,
corticosteroid treatment and HIV infection.3,87
In a retrospective study including 27 patients with
SEA, eight patients had to be re-operated due to a
residual or recurrent epidural mass.29 In these
patients, this was associated with the extent of the
abscess and the finding of granulation tissue during
the first operation.
The final neurological outcome correlates
strongly with the severity and duration of neurolo-
gical deficits prior to surgery.1,3,4,6,19 Stage III and IV
and a duration of more than 24–36 h show the worst
recovery rate. Accordingly, post-operative improve-
ment of neurological deficits has been correlated
with the rapidity of surgical intervention (within
24 h).4,8,45 Nevertheless, even timely surgical inter-
vention of patients presenting with neurological
deficits does not guarantee complete recovery.
Moreover, similar to other causes of spinal cord
compression, the time to regain neurological func-
tion significantly exceeds the duration until deficits
occurred. Therefore, the final neurological outcome
should not be evaluated prior to 1 year.10
Apart from neurological deficits due to spinal cord
compression, the outcome of SEA might also depend
on the recovery from concomitant meningitis or
encephalitis.
Unfortunately, one-third of patients suffering from
SEA still do not have a good outcome, as shown in a
recent series.5,8,14,44 In only 15% of these patients
was there no diagnostic delay,44 indicating that
neurological deficits are commonly not recognized
and that the urgency for surgical decompression is
often not realized. Increased awareness, rapid
recognition and quick involvement of a multi-
disciplinary team remain the key issues in clinical
practice. Only then will efficient diagnostic and
treatment concepts be assured and outcomes
improved.
Key points for clinical practice
The final neurological outcome correlates strongly
with the severity and duration of neurological
deficits prior to surgery. During the disease
course, persistence of an elevated CRP is a
prognostic factor. Complete loss of muscle activity
(paralysis) lasting longer than 24–36 h is unlikely to
improve.
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